Atom | Forecast for Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Due Dates: February 16, 2026 (estimated)

Funding Amounts: Not yet specified; R21 mechanism anticipated

Summary: Supports research to enhance clinical trial readiness for rare diseases by developing tools, measures, or characterizations that facilitate the advancement of therapeutics or diagnostics toward clinical trials.

Key Information: This is a forecasted opportunity; details and application instructions will be released in a future Notice of Funding Opportunity (NOFO).

Forecast for Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Sign in to see full grant listing